Professor Andrew Lloyd Q Fever Article

This page is for registered Australian healthcare professionals with a valid AHPRA number. To access this page please login below or register here.

Can’t find the answers you’re looking for?

ASK MED INFO <

Contact the CSL Seqirus Medical Information team on 1800 642 865 or fill out the form below.

First Name

Last Name

Email Address

Preferred Phone Number

Your Question

By providing my contact details including email address, I understand that CSL and its group legal entities (a full list available here) (‘CSL’) will use the personal information requested for purposes set out in this form. CSL may also use my personal information to provide information about products or services, as nominated by me. Further information about how CSL will handle my personal information, including who has access to it and how I can make an enquiry or exercise any rights in relation to my personal information can be viewed in the CSL Global Privacy Notice.

References

1. Eldin C et al. From Q fever to Coxiella burnetii infection: a paradigm change. Clinical Microbiology Reviews. 2017;30(1). 2. Australian Technical Advisory Group on Immunisation (ATAGI). Australian Immunisation Handbook, Australian Government Department of Health, Canberra, 2018, immunisationhandbook.health.gov.au . Accessed October 2019 3. Marmion B. A guide to Q fever and Q fever vaccination. CSL Biotherapies. 2009. 4. Parker NR et al. Q fever. Lancet. 2006; 367 (9511):679-88 5. Communicable Diseases Network of Australia. Q fever: CDNA National Guidelines for Public Health Units; [Updated Nov 17 2018; cited Oct 10 2019] https://www1.health.gov.au/internet/main/publishing.nsf/ Content/cdna-song-q-fever.htm 6. Hickie I et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. British Medical Journal. 2006;333:575 7. Wielders CCH et al. Strategies for early detection of chronic Q-fever: a systematic review. European Journal of Clinical Investigation. 2013;43 (6):616-39 8. Wegdam-Blans MC, et al. Chronic Q fever: review of the literature and a proposal of new diagnostic criteria. Journal of Infection 2012;64:247–59. 9. Melgar TA et al. Q Fever in Man: A One Health Paradigm Disease. In: Simoes JCC et al., editors. The Principles and Practice of Q fever. New York: Nova Science Publishers; 2017. p. 1-24 10. Anderson A et. al, Diagnosis and Management of Q Fever — United States, 2013: Recommendations from CDC and the Q Fever Working Group. Centers for Disease Control (CDC). March 29 2013. Available at: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6203a1.htm?s_cid=rr6203a1_w Last viewed August 2020. 11. Raijmakers RPH et al (2019). Long-term effect of cognitive behavioural therapy and doxycycline treatment for patients with Q fever fatigue syndrome: one-year follow-up of the Qure study. Journal of Psychosomatic Research 116 (2019) 62–67 12. Keijmel S et al Effectiveness of long-term doxycycline treatment and cognitive- behavioural therapy on fatigue severity in patients with Q fever fatigue syndrome (Qure Study): a randomized controlled trial. Clinical Infectious Diseases 2017;64(8):998–1005 13. Gidding H et al. Seroprevalence of Q fever among metropolitan and non-metropolitan blood donors in New South Wales and Queensland, 2014–2015. Medical Journal of Australia. 210 (7) 15 April 2019 14. Cameron B et al. Drought and Q fever: association between trends in incidence and rainfall in rural Australia. In: Simoes JCC et al., editors. The Principles and Practice of Q fever. New York: Nova Science Publishers; 2017. p. 301-15 15. SafeWork NSW 2016; Available at https://www.health.nsw.gov.au/Infectious/controlguideline/Pages/qfever.aspx. Last viewed November 2019 16. Seqirus Q-VAX Product Information. Last updated August 2019 17. Chiu CK & Durrheim DN. A review of the efficacy of human Q fever vaccine registered in Australia. NSW Public Health Bulletin 2007 Jul-Aug;18(7-8):133-6

The information a reader is about to be referred to may not comply with the Australian regulatory requirements.

Further information relevant to the Australian environment is available from the company or via the Product Information.

Ok Cancel

Professor Andrew Lloyd Article

Healthcare Professional Log In

Can’t find the answers you’re looking for?